NO20055136L - Farmasoytisk sammensetning som innbeffatter et immunosuppressivt stoff for bruk ved behandling av hudsykdommer - Google Patents
Farmasoytisk sammensetning som innbeffatter et immunosuppressivt stoff for bruk ved behandling av hudsykdommerInfo
- Publication number
- NO20055136L NO20055136L NO20055136A NO20055136A NO20055136L NO 20055136 L NO20055136 L NO 20055136L NO 20055136 A NO20055136 A NO 20055136A NO 20055136 A NO20055136 A NO 20055136A NO 20055136 L NO20055136 L NO 20055136L
- Authority
- NO
- Norway
- Prior art keywords
- immunosuppressant
- treatment
- pharmaceutical composition
- skin disorders
- combinations
- Prior art date
Links
- 229960003444 immunosuppressant agent Drugs 0.000 title abstract 2
- 230000001861 immunosuppressant effect Effects 0.000 title abstract 2
- 239000003018 immunosuppressive agent Substances 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 208000017520 skin disease Diseases 0.000 title 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract 3
- ABEXEQSGABRUHS-UHFFFAOYSA-N 16-methylheptadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC(C)C ABEXEQSGABRUHS-UHFFFAOYSA-N 0.000 abstract 1
- 206010012438 Dermatitis atopic Diseases 0.000 abstract 1
- 206010012442 Dermatitis contact Diseases 0.000 abstract 1
- 206010013786 Dry skin Diseases 0.000 abstract 1
- 210000001744 T-lymphocyte Anatomy 0.000 abstract 1
- 201000008937 atopic dermatitis Diseases 0.000 abstract 1
- 208000010247 contact dermatitis Diseases 0.000 abstract 1
- 229940008099 dimethicone Drugs 0.000 abstract 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 abstract 1
- 239000004205 dimethyl polysiloxane Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000037336 dry skin Effects 0.000 abstract 1
- 229960005150 glycerol Drugs 0.000 abstract 1
- 239000002955 immunomodulating agent Substances 0.000 abstract 1
- 229940121354 immunomodulator Drugs 0.000 abstract 1
- 230000002584 immunomodulator Effects 0.000 abstract 1
- 229940060384 isostearyl isostearate Drugs 0.000 abstract 1
- 239000003120 macrolide antibiotic agent Substances 0.000 abstract 1
- 239000004014 plasticizer Substances 0.000 abstract 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 abstract 1
- 239000011885 synergistic combination Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0307866.4A GB0307866D0 (en) | 2003-04-04 | 2003-04-04 | Pharmaceutical composition |
| PCT/EP2004/003513 WO2004087141A1 (en) | 2003-04-04 | 2004-04-02 | Pharmaceutical composition comprising an immunosuppressant for use in the treatment of skin diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20055136D0 NO20055136D0 (no) | 2005-11-02 |
| NO20055136L true NO20055136L (no) | 2006-01-04 |
Family
ID=9956229
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20055136A NO20055136L (no) | 2003-04-04 | 2005-11-02 | Farmasoytisk sammensetning som innbeffatter et immunosuppressivt stoff for bruk ved behandling av hudsykdommer |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20070276004A1 (is) |
| EP (1) | EP1613314A1 (is) |
| JP (1) | JP2006522059A (is) |
| CN (1) | CN1767826A (is) |
| AU (1) | AU2004226821A1 (is) |
| BR (1) | BRPI0409187A (is) |
| CA (1) | CA2521250A1 (is) |
| GB (1) | GB0307866D0 (is) |
| IS (1) | IS8105A (is) |
| MX (2) | MXPA05010703A (is) |
| NO (1) | NO20055136L (is) |
| RS (1) | RS20050739A (is) |
| WO (1) | WO2004087141A1 (is) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0506139D0 (en) * | 2005-03-24 | 2005-05-04 | Transphase Ltd | A transdermal topical composition and its uses |
| US9358400B2 (en) | 2005-10-14 | 2016-06-07 | Pacesetter, Inc. | Leadless cardiac pacemaker |
| US9168383B2 (en) | 2005-10-14 | 2015-10-27 | Pacesetter, Inc. | Leadless cardiac pacemaker with conducted communication |
| US10265265B2 (en) | 2007-03-15 | 2019-04-23 | Drug Delivery Solutions Limited | Topical composition |
| EP2016935A1 (en) * | 2007-07-09 | 2009-01-21 | Intendis GmbH | Pharmaceutical composition for topical application of poorly soluble compounds |
| WO2010088687A1 (en) | 2009-02-02 | 2010-08-05 | Nanostim, Inc. | Leadless cardiac pacemaker with secondary fixation capability |
| US9060692B2 (en) | 2010-10-12 | 2015-06-23 | Pacesetter, Inc. | Temperature sensor for a leadless cardiac pacemaker |
| US8543205B2 (en) | 2010-10-12 | 2013-09-24 | Nanostim, Inc. | Temperature sensor for a leadless cardiac pacemaker |
| US9020611B2 (en) | 2010-10-13 | 2015-04-28 | Pacesetter, Inc. | Leadless cardiac pacemaker with anti-unscrewing feature |
| EP3090779B1 (en) | 2010-12-13 | 2017-11-08 | Pacesetter, Inc. | Pacemaker retrieval systems |
| CN103429296A (zh) | 2010-12-13 | 2013-12-04 | 内诺斯蒂姆股份有限公司 | 递送导管系统和方法 |
| US9242102B2 (en) | 2010-12-20 | 2016-01-26 | Pacesetter, Inc. | Leadless pacemaker with radial fixation mechanism |
| CN103501764A (zh) * | 2011-03-03 | 2014-01-08 | 阿勒根公司 | 基于硅酮的眼科制剂 |
| US9511236B2 (en) | 2011-11-04 | 2016-12-06 | Pacesetter, Inc. | Leadless cardiac pacemaker with integral battery and redundant welds |
| WO2014022661A1 (en) | 2012-08-01 | 2014-02-06 | Nanostim, Inc. | Biostimulator circuit with flying cell |
| PT3273938T (pt) * | 2015-03-25 | 2021-02-02 | Gct Gmbh | Produto cosmético e concentrado para a produção do produto cosmético |
| JP6932180B2 (ja) * | 2016-04-04 | 2021-09-08 | エムシー２・セラピューティクス・リミテッドＭＣ２ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｌｉｍｉｔｅｄ | タクロリムスを含む局所組成物 |
| EP3542788A1 (en) | 2018-03-19 | 2019-09-25 | MC2 Therapeutics Limited | Topical composition comprising calcipotriol and betamethasone dipropionate |
| MX2024005473A (es) * | 2021-12-16 | 2024-05-22 | Procter & Gamble | Composicion acondicionadora para el cabello. |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH08133979A (ja) * | 1994-09-16 | 1996-05-28 | Sando Yakuhin Kk | 局所適用薬剤組成物 |
| ATE299017T1 (de) * | 1994-10-26 | 2005-07-15 | Novartis Pharma Gmbh | Arzneimittel |
| GB2327610B (en) * | 1994-11-04 | 1999-06-02 | Novartis Ag | Macrolide compositions |
| ES2230571T3 (es) * | 1995-12-28 | 2005-05-01 | Mitsubishi Pharma Corporation | `composicion farmaceutica destinada para la administracion topica que comprende el 2-amino-2-(2-(4-octilfenil)etil) propan-1,3-diol para el tratamiento de las enfermedades causadas por una alteracion inmunitaria. |
| GB9601120D0 (en) * | 1996-01-19 | 1996-03-20 | Sandoz Ltd | Organic compounds |
| DE59802564D1 (de) * | 1997-08-18 | 2002-01-31 | Neubourg Stephanie | Schaum-hautschutzcreme |
| DK1064942T3 (da) * | 1998-03-26 | 2004-11-01 | Fujisawa Pharmaceutical Co | Sustained release-fremstilling af et makrolid |
| GB9826656D0 (en) * | 1998-12-03 | 1999-01-27 | Novartis Ag | Organic compounds |
| JP2001064164A (ja) * | 1999-06-23 | 2001-03-13 | Health Science Center:Kk | 止痒皮膚塗布剤 |
| GB0003932D0 (en) * | 2000-02-18 | 2000-04-12 | Novartis Ag | Pharmaceutical compositions |
| PE20030828A1 (es) * | 2002-03-04 | 2003-11-04 | Novartis Ag | Composicion oftalmica que comprende ascomicina |
| GB0218996D0 (en) * | 2002-08-14 | 2002-09-25 | Novartis Ag | Organic compounds |
-
2003
- 2003-04-04 GB GBGB0307866.4A patent/GB0307866D0/en not_active Ceased
-
2004
- 2004-04-02 MX MXPA05010703A patent/MXPA05010703A/es not_active Application Discontinuation
- 2004-04-02 JP JP2006504966A patent/JP2006522059A/ja active Pending
- 2004-04-02 MX MXPA05010708A patent/MXPA05010708A/es unknown
- 2004-04-02 CA CA002521250A patent/CA2521250A1/en not_active Abandoned
- 2004-04-02 US US10/550,357 patent/US20070276004A1/en not_active Abandoned
- 2004-04-02 WO PCT/EP2004/003513 patent/WO2004087141A1/en not_active Ceased
- 2004-04-02 EP EP04725324A patent/EP1613314A1/en not_active Withdrawn
- 2004-04-02 CN CNA2004800084529A patent/CN1767826A/zh active Pending
- 2004-04-02 AU AU2004226821A patent/AU2004226821A1/en not_active Abandoned
- 2004-04-02 RS YUP-2005/0739A patent/RS20050739A/sr unknown
- 2004-04-02 BR BRPI0409187-6A patent/BRPI0409187A/pt not_active IP Right Cessation
-
2005
- 2005-10-31 IS IS8105A patent/IS8105A/is unknown
- 2005-11-02 NO NO20055136A patent/NO20055136L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| US20070276004A1 (en) | 2007-11-29 |
| WO2004087141A1 (en) | 2004-10-14 |
| MXPA05010703A (es) | 2005-12-12 |
| WO2004087141B1 (en) | 2005-01-06 |
| JP2006522059A (ja) | 2006-09-28 |
| RS20050739A (sr) | 2007-11-15 |
| AU2004226821A1 (en) | 2004-10-14 |
| IS8105A (is) | 2005-10-31 |
| CN1767826A (zh) | 2006-05-03 |
| GB0307866D0 (en) | 2003-05-14 |
| MXPA05010708A (es) | 2005-12-12 |
| NO20055136D0 (no) | 2005-11-02 |
| CA2521250A1 (en) | 2004-10-14 |
| EP1613314A1 (en) | 2006-01-11 |
| BRPI0409187A (pt) | 2006-04-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20055136L (no) | Farmasoytisk sammensetning som innbeffatter et immunosuppressivt stoff for bruk ved behandling av hudsykdommer | |
| BRPI0816214B8 (pt) | uso cosmético, composição cosmética e/ou dermatológica, e, métodos para o tratamento cosmético da pele, para o tratamento cosmético de sinais cutâneos de envelhecimento e/ou fotoenvelhecimento e para o tratamento cosmético para prevenir e/ou tratar substâncias queratinosas secas | |
| WO2008127373A3 (en) | Methods and devices for treating tissue | |
| DE59509751D1 (de) | Gegen hautalterung wirksame stoffe oder wirkstoffkombinationen und zubereitungen | |
| WO2005102252A3 (de) | Haut- und/oder haarmittel enthaltend verbindungen mit isoprenoider struktur | |
| NO20065195L (no) | Terapeutiske enzymformuleringer og anvendelser derav | |
| WO2005000245A3 (en) | Compositions and methods for increasing telomerase activity | |
| WO2010070675A3 (en) | Topical formulation(s) for the treatment of inflammation, skin and mucosal disorders and other diseases thereof | |
| DE60121303D1 (de) | Mittel, wie nikotinamide oder cadpr zur behandlung von hautkrankheiten | |
| NO20090305L (no) | Cyklosporin formuleringer | |
| WO2006015263A3 (en) | Lonidamine analogs | |
| BRPI0810948A8 (pt) | "composição hidratante, usos da composição e método para hidratar ou umidificar a pele" | |
| WO2006093784A3 (en) | Dosage forms of antibiotics and combinations of antibiotics ans symptomatic relief agents | |
| NO20080133L (no) | Azolopyridin-2-on derivater som lipase og fosfolipaseinhibitorer | |
| BR0311866A (pt) | Composições de saponinas ou sapogeninas para terapia de câncer | |
| BRPI0412989A (pt) | combinação farmacêutica útil para mobilização de célula-tronco | |
| NO20055474L (no) | Mediatorer av revers kolesteroltransport for behandling av hyperkolesterolemi | |
| DK1146886T3 (da) | Sojaekstrakt indeholdende lipider, fremgangsmåde til fremstilling heraf og farmaceutisk og kosmetisk sammensætning | |
| TW200801031A (en) | Steroid nitrooxyderivatives | |
| WO2004075867A3 (de) | Zubereitungen eines extraktes von eperua falcata und/oder dessen inhaltstoffe enthaltend | |
| WO2005042699A3 (en) | Modified polypeptides with therapeutic activity and methods of use | |
| WO2010043351A3 (de) | Polyamid-5-verbindungen in kosmetischen zubereitungen | |
| WO2006018454A3 (de) | Kosmetische zubereitung mit hyaluronsäure und saponinen zur behandlung von hautalterungserscheinungen | |
| WO2008034989A3 (fr) | Utilisation d'un extrait de quinoa comme actif cosmetique et pharmaceutique amincissant et/ou comme actif prevenant de la formation de nouvelles graisses dans le corps humain | |
| WO2002087533A8 (de) | Verwendung von klee-extrakt zur prophylaxe gegen und behandlung von degenerativen hauterscheinungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |